Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...

Still, many people turn to vitamins and supplements for weight loss. In fact, around 15% of people have tried weight loss ...

In good news for those averse to injections ... The people in the trial had an average weight loss of 5.8% after four weeks and saw improvements in their fasting plasma glucose.

Promising early data from an experimental trial of a new obesity treatment pill has sent shares of Danish pharmaceutical Novo Nordisk skyrocketing, Bloomberg reports. The drug, called amycretin ...

In that regard, usnic acid is not unlike ephedra, another weight-loss pill that is sold online and in many thousands of neighborhood health-food and drugstores. Ephedra has been implicated in the ...

Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...

You know, one day vitamin E is good for you ... Why would I use these supplements and then have trans-fatty acids in my diet? I mean you want to try to get people to be consistent and I think ...

Oral GLP-1 drug in study led to average weight loss of 8.2% in a month at a 100 ... and is expected to launch a Phase 2 trial of the pill version by the end of the year. Details of study design ...